Local view for "http://purl.org/linkedpolitics/eu/plenary/2007-04-23-Speech-1-119"
|Predicate||Value (sorted: default)|
|dcterms:Is Part Of|
|lpv:document identification number||
"Mr President, there are many European families with members suffering from serious diseases. There are also many medical researchers and therapists with the means to help those patients, and they are all waiting for this important piece of legislation. It will provide the common legislative framework which will make these innovative therapies more readily, more widely and more safely available. It is urgently required, it will be of great benefit and there is no reason for delaying its implementation by loading it with unnecessary ethical provisos and carve-outs that are impossible to agree with the Council. It has been firmly established that ethical restrictions are properly within the power of individual Member States if they wish to limit or forbid. Subsidiarity is the essential rule. But there is every reason to have a European standard for regulating the safe use of such therapies where they are used. So I ask my colleagues, and particularly my good friend the rapporteur, to let this vitally important piece of legislation proceed this week, so that agreement with the Council can be reached. Many of our less fortunate fellow Europeans will thank us when this legislation comes into effect, but they will have great difficulty understanding if it is further delayed, emasculated or stopped altogether by this Parliament. This is one of those occasions when it is really important for us to exercise our powers carefully and responsibly and let this matter be finalised."@en1
member; Committee of Inquiry into the crisis of the Equitable Life Assurance Society (2006-02-16--2007-06-19)3
Named graphs describing this resource:
The resource appears as object in 2 triples